APP and Alzheimer disease: Acknowledging the prominent and multifactorial role of Glu in the pathogenesis of AD, we found that blocking AT1R in APP/PS1 mice by losartan enhances the amount and activity of GS, which plays a pivotal role in the homeostasis of Glu in the brain [38].